The PCLC of ventilation covers a broad range of control targets. They can be grouped into controllers focusing on gas exchange, lung mechanics (protective ventilation), patient demand, and automation of clinical protocols.
Control based on gas exchange
The first application of PCLC in mechanical ventilation was presented by Saxton in 1953, with a publication appearing in 1957 [
15], where his team applied feedback control to the iron lung to regulate the etCO
2. In the same decade, Frumin developed an automated anesthesia system, which incorporated an etCO
2 feedback control system [
16,
25]. Both systems used the ventilation pressure as the actuating variable and were able to keep end-tidal CO
2 at the set target.
In 1971, Mitamura and colleagues controlled the mixed expired CO
2 using both tidal volume (
VT) and breathing frequency (
f) [
20]. Their system was able to keep PCO
2 at the target, even with extracorporeal CO
2 loading. Other groups focused on setting either
VT or
f automatically, with the clinician setting the other variable manually [
26,
27]. Digital control using computers for CO
2 control started with Coles et al. in 1973 [
26], and the number of publications about feedback control in ventilation increased. Coles et al. showed that the PCLC system maintained the etCO
2 at the target better than manual control [
26].
The availability of intravascular sensors for pH or PaCO
2 measurement introduced new closed-loop control systems. Schulz et al. used such a sensor and feedback control to respond to setpoint changes in PaCO
2 [
28]. The response dynamics of their system was, however, limited by the slow response time of the sensor. A similar sensor problem caused the system of Coon et al. [
29] to oscillate. The continuous intravascular sensors, however, failed to remain commercially available and their use has ceased. Without any clinical alternatives, the control of CO
2 was again based on the measurement of etCO
2. However, the increasing difference between PaCO
2 and etCO
2 in the pathological lung requires compensation [
20,
28,
30]. Approaches based on first principles to link etCO
2 and PaCO
2 were presented by Ohlson et al. [
30], but the authors could not compensate correctly when a large variation of cardiac output appeared.
An extensive list of CO
2 feedback control (often referred to as ventilation control) systems over the past 50 years is shown in Table
1. As can be seen, all systems presented so far have been limited to proof-of-concept studies.
Table 1
Chronological development of closed-loop ventilation for CO2 and pH control in vivo
1957 | | PI | etCO2 | Pinsp | Patients (n = 2) | x | o |
1957 | | PI | etCO2 | Pinsp | Patients (n = 64) | x | o |
1959 | | PI | etCO2 | Pinsp | Patients (n = 50) | x | o |
1968 | | PI | etCO2 | FiCO2 | Patient (n = 1) | x | o |
1971 | | Optimal | \(\dot {\mathrm {V}}\text {CO}_{2}\) | VT, f | Dogs (n = 18) | x | x |
1973 | | PI | etCO2 | VT | Sheep (n = 1) | x | o |
1974 | | PD | PaCO2 | VT | Patients (n = 11) | x | o |
1978 | | PID | pH | VT | Dogs (n = 30) | x | x |
1978 | | PI | etCO2 | f | Cat (n = 1) | o | x |
1982 | | PID | PaCO2 | f | Dogs (n = 18) | x | o |
1982 | | PID | etCO2 | VT | Dogs (n = 6) | o | x |
1984 | | P | etCO2 | VT | Dogs (n = 3) | x | x |
1985 | | PI | etCO2 | MV | Dogs (n = 5) | x | x |
1987 | | PI | etCO2 | VT | Dogs (n = 5) | x | x |
1994 | | Adaptive | etCO2 | VT | Patients (n = 10) | x | o |
1996 | | Fuzzy | etCO2 | VT, f | Patients (n = 30) | x | o |
2002 | | MPC | PaCO2 | MMV level | Patient (n = 1) | x | o |
2004 | | MPC | etCO2 | MV | Patients (n = 15) | x | x |
The focus was mostly on the control of CO
2 until the early 1970s, but in 1975, Mitamura [
36] developed a “dual control system” for both CO
2 and O
2. Here, the SpO
2 was measured using an ear oximeter and an on-off controller was used for changing the inhaled oxygen content. The controller was able to rectify the hypoxia.
Controlling only the oxygenation was performed in preterm infants by Beddis et al. [
37] in 1979; this was made possible by using an indwelling umbilical arterial oxygen electrode sensor. To evaluate their system, they compared the time spent at the oxygenation target using the controller to a clinician-in-the-loop system. This metric was also used by others [
38‐
44] and the automated system was as good or better than the manual procedure in all cases.
Yu et al. later used an oximeter on the tongue to control the oxygenation and implemented an adaptive controller in dogs [
19]. This system was able to rectify hypoxia and compensate for disturbances, such as positive end-expiratory pressure (PEEP) changes and one lung ventilation. In 1991, East et al. [
45] used both FiO
2 and PEEP to control PaO
2. Whether to change FiO
2 or PEEP was based on previous clinical protocols and the system kept the patients at the oxygenation target for up to 6 h [
45].
Further literature on oxygenation control is summarized in Table
2. The control of oxygenation using the fraction of inspired oxygen remains an active field of research, especially in neonates. A recent review of oxygenation control was published by Claure and Bancalari in 2013 [
46]. The systems presented by Claure et al. [
41], Urschitz et al. [
42], and Gajdos et al. [
44] have been developed further and are now commercially available as AVEA-CLiO2 (CareFusion, Yorba Linda, CA, USA), CLAC (Löwenstein Medical GmbH & Co. KG, Bad Ems, Germany), and SPOC (Fritz Stephan GmbH, Gackenbach, Germany), respectively.
Table 2
Chronological development of closed-loop ventilation for O2 control in vivo
1975 | | On/off | SaO2 | FiO2 | – | x | o |
1979 | | P | PaO2 | FiO2 | Neonates (n = 12) | o | o |
1985 | | Adaptive | tcPO2 | FiO2 | Dogs (n = 2) | x | o |
1987 | | Adaptive | SpO2 | FiO2 | Dogs (n = 8) | x | o |
1988 | | Robust | PaO2 | FiO2 | Neonates (n = 7) | o | x |
1991 | | PID | PaO2 | PEEP, FiO2 | Dogs (n = 4) | x | o |
1992 | | PID | SaO2 | FiO2 | Neonates (n = 14) | o | x |
1995 | | Expert | SaO2 | FiO2, PEEP | Patients (n = 6) | o | x |
1997 | | PID | SpO2 | FiO2 | Dogs (n = 6) | x | o |
2001 | | Rule-based | SpO2 | FiO2 | Neonates (n = 14) | o | x |
2004 | | Expert | SpO2 | FiO2 | Neonates (n = 12) | o | x |
2008 | | PID | SpO2 | FiO2 | Patients (n = 15) | x | o |
2017 | | Adaptive | SaO2 | FiO2 | Neonates (n = 7) | o | x |
2018 | | Adaptive | SpO2 | FiO2 | Neonates (n = 12) | o | x |
Importantly, the control of oxygenation has mostly been limited to using only the FiO2 so far. This closely reflects the clinical difficulty in correctly choosing the PEEP—not least because oxygenation alone is not a reliable measurement of a good PEEP.
A large disadvantage of most of the closed-loop ventilation strategies presented is that they focus only on gas exchange and do not consider lung mechanics and quantification of harm. In fact, achieving proper CO2 control may require excessive VT or peak inspiration pressure, which can cause ventilator-induced lung injury (VILI). With clinical ventilation strategies becoming focused on being protective and preventing VILI, this requirement also needed to be incorporated into closed-loop control. Hence, control considering lung mechanics is presented next.
Control considering lung mechanics
Mitamura et al. considered minimizing ventilatory work as a further goal of their controller as early as 1971 [
20]. The idea is closely related to that of Otis et al. [
50] from 1950, which suggests that there exists an optimal combination of respiratory rate and tidal volume for minimal work of breathing. This approach was also used by Tehrani [
51] and Laubscher [
52] in 1991 and 1994, respectively. Laubscher et al. showed that their controller was able to adapt to personalized respiratory mechanics in a study on six patients. Laubscher and colleagues advanced their adaptive lung ventilation (ALV) controller (1994) to a newer version called
adaptive support ventilation (ASV). Arnal et al. [
53] tested the ASV controller on 243 patients with different respiratory lung conditions and showed the ability of the controller to choose
VT–
f combinations related to actual personalized lung mechanics.
Rudowski et al. [
54] addressed the concerns of VILI directly with the peak respiratory power index, as an index of lung trauma, in 1991. Their controller adjusts ventilator settings to reduce the respiratory power index, while ensuring adequate gas exchange. A study with six patients showed promising results.
Many modern systems do not directly control the ventilator using lung mechanics, but rather apply hard limits to ensure that tidal volume and pressure stay within certain, evidence-based, limits.
Control based on patient demand
It is also important to note here that the majority of literature presented so far considers only controlled (mandatory) ventilation, i.e., the patient is passive. However, in many cases, the patient is allowed or expected to breathe spontaneously, meaning patient demand becomes important. Early work was performed by Younes et al. with proportional assist ventilation (PAV) in 1992 [
55]. This positive feedback control system amplified patient effort, according to the respiratory mechanics and level of assistance set by the operator. This ensures synchrony, while automatically adapting to patient load. For the initial version of PAV, the clinician required knowledge of the respiratory mechanics of the patient to set an appropriate controller gain, but the newer version, called PAV+, estimates the individual respiratory mechanics automatically [
56,
57].
In 1996, Iotti et al. proposed
P0.1 closed-loop control ventilation, whereby the drop in airway occlusion pressure during the first 0.1 s of inspiration is used to estimate patient work [
58]. Two independent controllers, one for
P0.1 and the other for alveolar volume, are fed into a merged control algorithm which changes the level of pressure support. The authors showed that inspiration activity of the patient can be stabilized at a desired level using
P0.1, thus allowing for the unloading of the inspiratory muscles.
A direct coupling to the physiological neural output of the respiratory system would be helpful for optimal support during spontaneous breathing. An attempt to couple a respirator to phrenic nerve activity was performed in 1970 on animals [
59], but this was not feasible in humans. Instead, Sinderby et al. [
60] used the diaphragmatic electrical activity (EAdi) for neuro-ventilatory coupling to adjust the level of ventilatory support. This system requires the placement of an esophageal catheter. This system is commercially available as neurally adjusted ventilatory assist (NAVA) (Maquet Critical Care AB, Solna, Sweden). Improved patient-ventilator synchrony for this system was shown by [
61], but the authors noted that the clinical impact thereof still needed to be determined.